首页 | 本学科首页   官方微博 | 高级检索  
     

难治性癫(癎)的发病机制研究进展及前景展望
引用本文:黄绍平,李丹. 难治性癫(癎)的发病机制研究进展及前景展望[J]. 临床儿科杂志, 2009, 27(11)
作者姓名:黄绍平  李丹
作者单位:西安交通大学医学院第二附属医院儿内科,陕西西安,710004;西安交通大学医学院第二附属医院儿内科,陕西西安,710004
摘    要:癫(癎)是儿童常见的神经系统疾病,近年来有关难治性癫(癎)发病机制的研究取得一些突破性进展.文章就难治性癫(癎)发病机制的研究现状进行综述,主要包括4个方面的内容,其中多药转运体表达增多可能导致进入脑组织的药物浓度降低是产生耐药的主要因素,文章重点阐述多药耐药基因和难治性癫(癎)的关系,并对难治性癫(癎)的进一步研究方向和临床应用前景提出新的思路.

关 键 词:癫(癎)  耐药性  神经网络重组  离子通道  抗癫痫药物  多药耐药转运体

Progress of pathogenesis and potential future implications of refractory epilepsy
HUANG Shao-ping,LI Dan. Progress of pathogenesis and potential future implications of refractory epilepsy[J]. The Journal of Clinical Pediatrics, 2009, 27(11)
Authors:HUANG Shao-ping  LI Dan
Abstract:Epilepsy is a common neurological disorder of children. Research in recent years on the mechanism of refractable epilepsy has made some breakthrough. Four concepts have been put forward to explain the development of pharmacoresistance. The transporter hypothesis have become the focus, which contends that the expression or function of multidrug transporters in the brain is augmented, leading to impaired access of antiepileptic drugs to central nervous system targets. An emerging understanding of these underlying molecular and cellular mechanisms is likely to provide important impetus for the development of new pharmacological treatment strategies and clinical test facility.
Keywords:epilepsy  pharmacoresistance  reconstitution of neural network  ion channel  anti-epileptic drugs  muhidrug transporter
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号